previous slide

Loading ...

Loading ...
next slide
Dr. Michael Raizman


Active Studies (enrolling patients):

Corneal  Crosslinking (Phase III) - To evaluate the safety and efficacy of epithelium-on corneal collagen cross-linking (CXL) in impeding the progression of, and/or reducing coreal cuvature (Kmax) in eyes with progressive keratoconus.


Back to research home page

Find Our Doctors

Request an Appointment
New & Established Patients
* required field   *   *   *   *     *     * Include Preferred Day & Time

Refill a Prescription
Place your order 24/7. OCB utilizes a secure portal called Patient Gateway for prescription refills

Newsletter OCB Summer Newsletter Download ...
View past eNewsletters
Sign Up for OCB's eNewsletter * *
About OCB
OCB Boston
50 Staniford Street, Suite 600
Boston, MA 02114

PH 1.800.635.0489
FAX 1.617.723.7028
Quick Links
Stay Connected
@ OCB All Rights Reserved | Careers | Employee Login
Site Development: Linking Shores Consulting Inc.

Loading ...